Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy.
Ontology highlight
ABSTRACT: Cutaneous malignant melanoma remains a therapeutic challenge, and patients with advanced disease have limited survival. Photodynamic therapy (PDT) has been successfully used to treat many malignancies, and it may show promise as an antimelanoma modality. However, high melanin levels in melanomas can adversely affect PDT effectiveness. Herein the extent of melanin contribution to melanoma resistance to PDT was investigated in a set of melanoma cell lines that markedly differ in the levels of pigmentation; 3 new bacteriochlorins successfully overcame the resistance. Cell killing studies determined that bacteriochlorins are superior at (LD(50) approximately 0.1 microM) when compared with controls such as the FDA-approved Photofrin (LD(50) approximately 10 microM) and clinically tested LuTex (
SUBMITTER: Mroz P
PROVIDER: S-EPMC2923353 | biostudies-literature | 2010 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA